-
- 抗原 See all SUMO1 抗体
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This SUMO1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 纯化方法
- This antibody is purified through a protein G column, followed by dialysis against PBS.
- 免疫原
- Purified recombinant GST-SUMO1 protein was used as immunogen.
- 克隆位点
- 66AT1320
- 亚型
- IgG1
- Top Product
- Discover our top product SUMO1 Primary Antibody
-
-
- 应用备注
- WB: 1:100~500
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 有效期
- 6 months
-
-
Gold nanoparticles as a platform for creating a multivalent poly-SUMO chain inhibitor that also augments ionizing radiation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Issue 11, pp. 4092-7, (2012) (PubMed).
: "Entropy-driven mechanism of an E3 ligase." in: Biochemistry, Vol. 50, Issue 25, pp. 5757-66, (2011) (PubMed).
: "Association between polymorphisms at small ubiquitin-like modifier 1 and nonsyndromic orofacial clefts in Western China." in: DNA and cell biology, Vol. 29, Issue 11, pp. 675-80, (2010) (PubMed).
: "Association between genetic variants of reported candidate genes or regions and risk of cleft lip with or without cleft palate in the polish population." in: Birth defects research. Part A, Clinical and molecular teratology, Vol. 88, Issue 7, pp. 538-45, (2010) (PubMed).
: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
: "Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia." in: PLoS ONE, Vol. 5, Issue 7, pp. e11493, (2010) (PubMed).
: "Stability of thioester intermediates in ubiquitin-like modifications." in: Protein science : a publication of the Protein Society, Vol. 18, Issue 12, pp. 2492-9, (2009) (PubMed).
: "A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients." in: Vox sanguinis, Vol. 60, Issue 1, pp. 23-7, (1991) (PubMed).
: "
-
Gold nanoparticles as a platform for creating a multivalent poly-SUMO chain inhibitor that also augments ionizing radiation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Issue 11, pp. 4092-7, (2012) (PubMed).
-
- 抗原
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
- 别名
- SUMO1 (SUMO1 产品)
- 背景
- This gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last four amino acids of the carboxy-terminus have been cleaved off. Several pseudogenes have been reported for this gene. Alternate transcriptional splice variants encoding different isoforms have been characterized.
- 分子量
- 11557
- NCBI登录号
- NP_001005781, NP_001005782, NP_003343
- UniProt
- P63165
- 途径
- M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
-